December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Nedocromil Sodium 2% Ophthalmic Solution vs. Artificial Tears Used Twice Daily in Patients With Contact Lens Intolerance and a History of Allergic Conjunctivitis
Author Affiliations & Notes
  • J Tauber
    Hunkler Eye Centers Kansas City MO
  • Footnotes
    Commercial Relationships   J. Tauber, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 116. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J Tauber; Nedocromil Sodium 2% Ophthalmic Solution vs. Artificial Tears Used Twice Daily in Patients With Contact Lens Intolerance and a History of Allergic Conjunctivitis . Invest. Ophthalmol. Vis. Sci. 2002;43(13):116.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To evaluate the safety and efficacy of nedocromil 2% ophthalmic solution in patients with contact lens intolerance and a history of allergic conjunctivitis. Methods:A multicenter, randomized, investigator-masked, parallel group clinical trial. Patients (n=59) with a history of seasonal or perennial allergic conjunctivitis and disposable (≷ 1 day and ≤ 1 month) lens use for at least 30 days prior to study entry were randomized to receive nedocromil or artificial tears BID. Study visits were at baseline, week 1, and week 4. The primary outcome measures were change in contact lens wear time and physician evaluation of the overall effect of the study medications. Results:The mean contact lens wear time at the baseline evaluation was 6.4 hours in the nedocromil-treatment group and 6.5 hours in the tears group (P=.623). Both study medications produced a significant increase in daily contact lens wear time after 4 weeks of use (P≤.005). At the week 4 follow-up visit, the mean increase in daily contact lens wear time was 1.7 hours in the nedocromil group and 0.7 hours in the tears group (P=.026). Investigators noted at least 50% improvement in allergy symptoms in a significantly greater percentage of nedocromil patients (67.7%, 21/31) than in tears patients (35.7%, 10/28) after 4 weeks of study medications (P=.014). Conclusion:Both nedocromil and artificial tears extended the daily contact lens wearing time in patients with a history of lens intolerance and allergic conjunctivitis. However, the increase in daily contact lens wearing time provided by nedocromil was significantly greater than that provided by artificial tears after 4 weeks of treatment. These findings suggest that nedocromil may increase contact lens tolerability and prolong daily contact lens wearing time in patients who choose to wear contact lenses despite symptoms of ocular allergy.

Keywords: 357 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • 367 contact lens • 365 conjunctiva 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×